https://www.selleckchem.com/products/ABT-888.html
To evaluate the rate of thrombosis, bleeding and mortality comparing anticoagulant doses in critically ill COVID-19 patients. Retrospective observational and analytical cohort study. COVID-19 patients admitted to the intensive care unit of a tertiary hospital between March and April 2020. 201 critically ill COVID-19 patients were included. Patients were categorized into three groups according to the highest anticoagulant dose received during hospitalization prophylactic, intermediate and therapeutic. The incidence of venous thromboembol
Like
Comment
Share
